| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $104.9M | — | +262.0% |
| Cost of Revenue | $82.5M | — | +198.1% |
| Gross Profit | $22.4M | — | +1622.2% |
| R&D Expense | $1.1M | — | +23.3% |
| SG&A Expense | $3.7M | — | +19.1% |
| Operating Income | $8.6M | — | +187.7% |
| Pre-tax Income | $8.6M | — | +191.1% |
| Net Income | $8.6M | — | +191.1% |
| EPS (Basic) | $0.03 | — | +200.0% |
| EPS (Diluted) | $0.03 | — | +200.0% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.0M | -46.5% | +17.8% |
| Accounts Receivable | $3.0M | +24.9% | +56.9% |
| Inventory | $41.2M | +1119.1% | +1730.6% |
| Current Assets | $85.5M | +77.4% | +180.1% |
| Total Assets | $87.6M | +77.1% | +170.2% |
| Current Liabilities | $76.3M |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$21.8M | — | -116.7% |
| Capital Expenditures | $13K | — | +0.0% |
| Investing Cash Flow | -$13K | — | +0.0% |
| Financing Cash Flow | $6.7M | — | +538.7% |
| Free Cash Flow | -$21.8M | — | -116.6% |
| +67.5% |
| Total Liabilities | $77.2M | +41.1% | +67.4% |
| Stockholders' Equity | $10.4M | +300.7% | +176.4% |